Logo image of OSPN

ONESPAN INC (OSPN) Stock Fundamental Analysis

NASDAQ:OSPN - US68287N1000 - Common Stock

14.56 USD
+0.57 (+4.07%)
Last: 8/22/2025, 8:00:02 PM
14.56 USD
0 (0%)
After Hours: 8/22/2025, 8:00:02 PM
Fundamental Rating

6

Overall OSPN gets a fundamental rating of 6 out of 10. We evaluated OSPN against 283 industry peers in the Software industry. OSPN scores excellent points on both the profitability and health parts. This is a solid base for a good stock. OSPN scores decently on growth, while it is valued quite cheap. This could make an interesting combination. With these ratings, OSPN could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

OSPN had positive earnings in the past year.
In the past year OSPN had a positive cash flow from operations.
In the past 5 years OSPN reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: OSPN reported negative operating cash flow in multiple years.
OSPN Yearly Net Income VS EBIT VS OCF VS FCFOSPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

With an excellent Return On Assets value of 16.78%, OSPN belongs to the best of the industry, outperforming 93.29% of the companies in the same industry.
The Return On Equity of OSPN (24.70%) is better than 89.40% of its industry peers.
Looking at the Return On Invested Capital, with a value of 15.84%, OSPN belongs to the top of the industry, outperforming 92.93% of the companies in the same industry.
Industry RankSector Rank
ROA 16.78%
ROE 24.7%
ROIC 15.84%
ROA(3y)0.75%
ROA(5y)-1.63%
ROE(3y)0.35%
ROE(5y)-3%
ROIC(3y)N/A
ROIC(5y)N/A
OSPN Yearly ROA, ROE, ROICOSPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

With an excellent Profit Margin value of 24.90%, OSPN belongs to the best of the industry, outperforming 90.11% of the companies in the same industry.
In the last couple of years the Profit Margin of OSPN has grown nicely.
OSPN has a Operating Margin of 21.80%. This is amongst the best in the industry. OSPN outperforms 88.34% of its industry peers.
OSPN's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 73.93%, OSPN is doing good in the industry, outperforming 62.19% of the companies in the same industry.
OSPN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.8%
PM (TTM) 24.9%
GM 73.93%
OM growth 3YN/A
OM growth 5Y29.31%
PM growth 3YN/A
PM growth 5Y49.76%
GM growth 3Y2.52%
GM growth 5Y1.64%
OSPN Yearly Profit, Operating, Gross MarginsOSPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so OSPN is still creating some value.
Compared to 1 year ago, OSPN has more shares outstanding
OSPN has less shares outstanding than it did 5 years ago.
OSPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
OSPN Yearly Shares OutstandingOSPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
OSPN Yearly Total Debt VS Total AssetsOSPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 4.87 indicates that OSPN is not in any danger for bankruptcy at the moment.
OSPN's Altman-Z score of 4.87 is fine compared to the rest of the industry. OSPN outperforms 70.67% of its industry peers.
There is no outstanding debt for OSPN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.87
ROIC/WACC1.4
WACC11.28%
OSPN Yearly LT Debt VS Equity VS FCFOSPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

OSPN has a Current Ratio of 1.77. This is a normal value and indicates that OSPN is financially healthy and should not expect problems in meeting its short term obligations.
OSPN has a Current ratio of 1.77. This is comparable to the rest of the industry: OSPN outperforms 55.48% of its industry peers.
OSPN has a Quick Ratio of 1.65. This is a normal value and indicates that OSPN is financially healthy and should not expect problems in meeting its short term obligations.
OSPN's Quick ratio of 1.65 is in line compared to the rest of the industry. OSPN outperforms 51.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.65
OSPN Yearly Current Assets VS Current LiabilitesOSPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.33% over the past year.
OSPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.39% yearly.
The Revenue has decreased by -2.79% in the past year.
Measured over the past years, OSPN shows a decrease in Revenue. The Revenue has been decreasing by -0.83% on average per year.
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5Y19.39%
EPS Q2Q%9.68%
Revenue 1Y (TTM)-2.79%
Revenue growth 3Y4.27%
Revenue growth 5Y-0.83%
Sales Q2Q%-1.77%

3.2 Future

OSPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.37% yearly.
The Revenue is expected to grow by 3.25% on average over the next years.
EPS Next Y11.48%
EPS Next 2Y6.01%
EPS Next 3Y4.37%
EPS Next 5YN/A
Revenue Next Year3.38%
Revenue Next 2Y4.23%
Revenue Next 3Y3.25%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OSPN Yearly Revenue VS EstimatesOSPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
OSPN Yearly EPS VS EstimatesOSPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.71 indicates a reasonable valuation of OSPN.
Based on the Price/Earnings ratio, OSPN is valued cheaply inside the industry as 88.69% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.24. OSPN is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 9.89, the valuation of OSPN can be described as reasonable.
Based on the Price/Forward Earnings ratio, OSPN is valued cheaply inside the industry as 92.58% of the companies are valued more expensively.
OSPN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.82.
Industry RankSector Rank
PE 10.71
Fwd PE 9.89
OSPN Price Earnings VS Forward Price EarningsOSPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

OSPN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OSPN is cheaper than 92.93% of the companies in the same industry.
OSPN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OSPN is cheaper than 94.35% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.2
EV/EBITDA 7.21
OSPN Per share dataOSPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

OSPN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OSPN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.93
PEG (5Y)0.55
EPS Next 2Y6.01%
EPS Next 3Y4.37%

3

5. Dividend

5.1 Amount

OSPN has a Yearly Dividend Yield of 3.43%.
OSPN's Dividend Yield is rather good when compared to the industry average which is at 48.84. OSPN pays more dividend than 98.23% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, OSPN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.43%

5.2 History

OSPN is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
OSPN Yearly Dividends per shareOSPN Yearly Dividends per shareYearly Dividends per share 2025 0.1 0.2 0.3

5.3 Sustainability

DPN/A
EPS Next 2Y6.01%
EPS Next 3Y4.37%
OSPN Yearly Income VS Free CF VS DividendOSPN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

ONESPAN INC

NASDAQ:OSPN (8/22/2025, 8:00:02 PM)

After market: 14.56 0 (0%)

14.56

+0.57 (+4.07%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners97.06%
Inst Owner Change0.22%
Ins Owners1.34%
Ins Owner Change2.14%
Market Cap557.94M
Analysts80
Price Target18.7 (28.43%)
Short Float %4.55%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield 3.43%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date08-15 2025-08-15 (0.12)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.6%
Min EPS beat(2)13.86%
Max EPS beat(2)35.33%
EPS beat(4)3
Avg EPS beat(4)27.94%
Min EPS beat(4)-7.73%
Max EPS beat(4)70.28%
EPS beat(8)7
Avg EPS beat(8)143.03%
EPS beat(12)9
Avg EPS beat(12)92.39%
EPS beat(16)11
Avg EPS beat(16)69.4%
Revenue beat(2)0
Avg Revenue beat(2)-0.66%
Min Revenue beat(2)-0.68%
Max Revenue beat(2)-0.64%
Revenue beat(4)2
Avg Revenue beat(4)0.54%
Min Revenue beat(4)-0.68%
Max Revenue beat(4)2.75%
Revenue beat(8)6
Avg Revenue beat(8)3.91%
Revenue beat(12)9
Avg Revenue beat(12)3.62%
Revenue beat(16)11
Avg Revenue beat(16)2.98%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-13.88%
EPS NQ rev (3m)-17.25%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-3.93%
Revenue NQ rev (3m)-3.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.71
Fwd PE 9.89
P/S 2.31
P/FCF 10.2
P/OCF 8.98
P/B 2.3
P/tB 4.33
EV/EBITDA 7.21
EPS(TTM)1.36
EY9.34%
EPS(NY)1.47
Fwd EY10.11%
FCF(TTM)1.43
FCFY9.8%
OCF(TTM)1.62
OCFY11.14%
SpS6.29
BVpS6.34
TBVpS3.36
PEG (NY)0.93
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 16.78%
ROE 24.7%
ROCE 20.06%
ROIC 15.84%
ROICexc 24.57%
ROICexgc 75.75%
OM 21.8%
PM (TTM) 24.9%
GM 73.93%
FCFM 22.67%
ROA(3y)0.75%
ROA(5y)-1.63%
ROE(3y)0.35%
ROE(5y)-3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y39.04%
ROICexc growth 3YN/A
ROICexc growth 5Y36.55%
OM growth 3YN/A
OM growth 5Y29.31%
PM growth 3YN/A
PM growth 5Y49.76%
GM growth 3Y2.52%
GM growth 5Y1.64%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 84.43%
Cap/Sales 3.09%
Interest Coverage 250
Cash Conversion 101.2%
Profit Quality 91.06%
Current Ratio 1.77
Quick Ratio 1.65
Altman-Z 4.87
F-Score7
WACC11.28%
ROIC/WACC1.4
Cap/Depr(3y)125.33%
Cap/Depr(5y)85.22%
Cap/Sales(3y)3.82%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.33%
EPS 3YN/A
EPS 5Y19.39%
EPS Q2Q%9.68%
EPS Next Y11.48%
EPS Next 2Y6.01%
EPS Next 3Y4.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.79%
Revenue growth 3Y4.27%
Revenue growth 5Y-0.83%
Sales Q2Q%-1.77%
Revenue Next Year3.38%
Revenue Next 2Y4.23%
Revenue Next 3Y3.25%
Revenue Next 5YN/A
EBIT growth 1Y60.22%
EBIT growth 3YN/A
EBIT growth 5Y28.24%
EBIT Next Year27.68%
EBIT Next 3Y11.32%
EBIT Next 5YN/A
FCF growth 1Y578.97%
FCF growth 3YN/A
FCF growth 5Y33.85%
OCF growth 1Y6987.56%
OCF growth 3YN/A
OCF growth 5Y25%